Filling in the Gaps: Sequencing the Entire Human Genome
The Scientist Speaks

The Scientist Speaks - Filling in the Gaps: Sequencing the Entire Human Genome

Karen Miga discusses how she and collaborators sequenced the missing parts of the human genome almost two decades after the first Human Genome Project published its results.

Share

Sequencing the human genome in the early 2000s was an incredible feat, but the sequence was incomplete. Recently, a consortium of researchers published a telomere-to-telomere assembly of a complete human X chromosome. This accomplishment was made possible by advances in sequencing technology, allowing researchers to address the previous technical difficulties in analyzing challenging genomic regions. Filling in these gaps of the human genome represents a breakthrough in human genetics and opens the door to a wealth of future studies that will undoubtedly advance our understanding of health and disease. 

In this episode, Iris Kulbatski from The Scientist’s Creative Services Team spoke with Karen Miga, an assistant professor of biomolecular engineering at the University of California, Santa Cruz’s Genomics Institute and a recent honoree on TIME’s list of the 100 most influential people of 2022, to learn more.

More on this topic 

The Scientist Speaks is a podcast produced by The Scientist’s Creative Services Team. Our podcast is by scientists and for scientists. Once a month, we bring you the stories behind news-worthy molecular biology research. 

Speaker

Miga.jpg 


Karen Miga, PhD
Assistant Professor
Biomolecular Engineering, University of California, Santa Cruz
Associate Director
University of California, Santa Cruz Genomics Institute




Top Image Credit:

istock

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies